View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

   reports
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
12/20/24 December 20, 2024 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/17/24 September 17, 2024 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
07/31/24 July 31, 2024 1 EN
EUR 159.17
TKPHF Takeda Pharmace...

Moody's Ratings assigns (P)Baa1 to Takeda's Shelf, Baa1 to USD notes d...

1/4NEWSContact:東京 東京円城 ディーン セメトコ 真理子主任格付アナリスト／VPシニア・アナリスト 格付責任者／ｱｿｼｴｲﾄ･ﾏﾈｰｼﾞﾝｸﾞ･ﾃﾞｨﾚｸﾀｰコーポレート・ファイナンス・グループ コーポレート・ファイナンス・グループムーディーズ・ジャパン株式会社 ムーディーズ・ジャパン株式会社お客様専用電話番号：03-5408-4100報道関係者電話番号：03-5408-4110お客様専用電話番号：03-5408-4100報道関係者電話番号：03-5408-4110[MJKK]武田薬品の発行登録枠に(P)Baa1、及び米ドル建て社債にBaa1の格付を付与  2024年6月28日...

TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
06/28/24 June 28, 2024 1 EN
EUR 221.08
TKPHF Takeda Pharmace...

Takeda Pharmaceutical Company Limited: Update to credit analysis

Our credit view of Takeda Pharmaceutical Company Limited reflects its diversified drug portfolio constrained by its still high leverage post the Shire acquisition.

TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
06/25/24 June 25, 2024 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
03/21/24 March 21, 2024 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
12/06/23 December 6, 2023 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/05/23 September 5, 2023 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
08/08/23 August 8, 2023 1 EN
EUR 221.08
TKPHF Takeda Pharmace...

Takeda Pharmaceutical Company Limited: Update following upgrade to Baa...

Our credit view of Takeda reflects its robust late-stage pipeline, with in-house development of several potential blockbusters, offset by its high debt and rising competition.

TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
06/27/23 June 27, 2023 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
03/10/23 March 10, 2023 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
12/08/22 December 8, 2022 1 EN
EUR 221.08
TKPHF Takeda Pharmace...

Takeda Pharmaceutical Company Limited: Update to credit analysis

Our credit view of Takeda reflects its robust late-stage pipeline, with in-house development of several potential blockbusters, offset by its high debt and rising competition.

TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
11/16/22 November 16, 2022 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/12/22 September 12, 2022 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
08/05/22 August 5, 2022 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
03/21/22 March 21, 2022 1 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
12/07/21 December 7, 2021 1 EN
EUR 176.86
TKPHF Takeda Pharmace...

Takeda Pharmaceutical Company Limited: Planned share buybacks a credit...

The share buyback will reduce funds that could otherwise service debt obligations, but the company's excellent liquidity means a limited impact on leverage.

TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
11/01/21 November 1, 2021 3 EN
EUR 221.08
TKPHF Takeda Pharmace...

Takeda Pharmaceutical Company Limited: Update following change in outl...

Our credit view of Takeda reflects its leading position in Japan and rare diseases, against its higher debt following the Shire acquisition, with some leverage reduction yet to be done.

TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
10/04/21 October 4, 2021 11 EN
TKPHF TAKEDA PHARMACEUTICAL COMPANY LIMITED
09/13/21 September 13, 2021 1 EN
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest
Save

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search
Save

ResearchPool Subscriptions

Get the most out of your insights

Get in touch